nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A1—Methotrexate—breast cancer	0.0368	1	CbGbCtD
Gamma Hydroxybutyric Acid—SLC52A2—nipple—breast cancer	0.0141	0.0702	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—embryo—breast cancer	0.0116	0.0579	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—skin of body—breast cancer	0.009	0.0449	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—endometrium—breast cancer	0.00848	0.0424	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—nipple—breast cancer	0.00799	0.0399	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—pituitary gland—breast cancer	0.00768	0.0383	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—adipose tissue—breast cancer	0.00765	0.0382	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—female reproductive system—breast cancer	0.00703	0.0351	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Gemcitabine—breast cancer	0.00694	1	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC52A2—adrenal gland—breast cancer	0.00686	0.0343	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—bone marrow—breast cancer	0.00663	0.0331	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—female gonad—breast cancer	0.00639	0.0319	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—epithelium—breast cancer	0.00564	0.0282	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—endometrium—breast cancer	0.00506	0.0253	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—uterus—breast cancer	0.00466	0.0233	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—pituitary gland—breast cancer	0.00458	0.0229	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—adipose tissue—breast cancer	0.00456	0.0228	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—uterus—breast cancer	0.00445	0.0222	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—pituitary gland—breast cancer	0.00437	0.0218	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—adipose tissue—breast cancer	0.00435	0.0217	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—female reproductive system—breast cancer	0.00419	0.0209	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—breast cancer	0.00411	0.0205	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—adrenal gland—breast cancer	0.00409	0.0204	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—female reproductive system—breast cancer	0.004	0.02	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—bone marrow—breast cancer	0.00396	0.0198	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—adrenal gland—breast cancer	0.0039	0.0195	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—female gonad—breast cancer	0.00381	0.019	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—endocrine gland—breast cancer	0.00355	0.0177	CbGeAlD
Gamma Hydroxybutyric Acid—GABRB1—pituitary gland—breast cancer	0.00351	0.0175	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—epithelium—breast cancer	0.00343	0.0171	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—endocrine gland—breast cancer	0.00338	0.0169	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—endometrium—breast cancer	0.00307	0.0153	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—uterus—breast cancer	0.00283	0.0141	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—pituitary gland—breast cancer	0.00278	0.0139	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—adipose tissue—breast cancer	0.00277	0.0138	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—female reproductive system—breast cancer	0.00255	0.0127	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—adrenal gland—breast cancer	0.00248	0.0124	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—breast cancer	0.00245	0.0122	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—breast cancer	0.00234	0.0117	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—female gonad—breast cancer	0.00232	0.0116	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—endocrine gland—breast cancer	0.00215	0.0108	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—breast cancer	0.00149	0.00744	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MMP1—breast cancer	0.000175	0.000892	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GPX4—breast cancer	0.000175	0.000892	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SULT1A1—breast cancer	0.000175	0.000892	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CDK2—breast cancer	0.000172	0.000876	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PLAU—breast cancer	0.000172	0.000876	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—IDH1—breast cancer	0.000171	0.000871	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA1—breast cancer	0.000171	0.000871	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NAT2—breast cancer	0.000169	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—COMT—breast cancer	0.000169	0.000861	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000168	0.000857	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CAV1—breast cancer	0.000168	0.000856	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—COX11—breast cancer	0.000166	0.000849	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TGFB2—breast cancer	0.000163	0.000834	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—THBS1—breast cancer	0.000163	0.00083	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000162	0.000826	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GATA3—breast cancer	0.00016	0.000818	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—FN1—breast cancer	0.00016	0.000814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000159	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS2—breast cancer	0.000158	0.000805	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000157	0.000799	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000156	0.000796	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—breast cancer	0.000155	0.000789	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CG—breast cancer	0.000153	0.000779	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CDA—breast cancer	0.000152	0.000777	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SHMT1—breast cancer	0.000152	0.000777	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EGF—breast cancer	0.000151	0.00077	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—DPYD—breast cancer	0.000148	0.000755	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MED12—breast cancer	0.000148	0.000755	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLCO1B1—breast cancer	0.000146	0.000748	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC2A5—breast cancer	0.000146	0.000748	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALDOA—breast cancer	0.000146	0.000744	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ALB—breast cancer	0.000145	0.000741	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNB1—breast cancer	0.000144	0.000734	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—breast cancer	0.000142	0.000725	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—APRT—breast cancer	0.000141	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA3—breast cancer	0.000141	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000141	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000141	0.000717	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC2A2—breast cancer	0.00014	0.000717	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IGF1—breast cancer	0.00014	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.00014	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT2—breast cancer	0.00014	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—RAF1—breast cancer	0.000139	0.000709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTR—breast cancer	0.000138	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCG2—breast cancer	0.000138	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CPT1A—breast cancer	0.000138	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000137	0.000699	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000136	0.000695	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPGDS—breast cancer	0.000135	0.000689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CD—breast cancer	0.000134	0.000685	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HBA1—breast cancer	0.000134	0.000684	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ESRRA—breast cancer	0.000133	0.000679	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ANGPTL4—breast cancer	0.000133	0.000679	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SERPINE1—breast cancer	0.000133	0.000678	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ALB—breast cancer	0.000133	0.000676	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLAUR—breast cancer	0.000132	0.000674	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—breast cancer	0.000131	0.000671	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—RAF1—breast cancer	0.000131	0.00067	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTT1—breast cancer	0.000131	0.000668	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACHE—breast cancer	0.000131	0.000668	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.00013	0.000663	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLG—breast cancer	0.000129	0.000659	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS3—breast cancer	0.000127	0.000647	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HADHB—breast cancer	0.000126	0.000643	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPI—breast cancer	0.000126	0.000643	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000125	0.00064	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP17A1—breast cancer	0.000124	0.000632	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Immune system disorder—Methotrexate—breast cancer	0.000124	0.000221	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Fluorouracil—breast cancer	0.000124	0.000221	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Methotrexate—breast cancer	0.000124	0.000221	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Irinotecan—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Mitoxantrone—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Mitoxantrone—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Irinotecan—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Methotrexate—breast cancer	0.000123	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ENO1—breast cancer	0.000123	0.000626	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS1—breast cancer	0.000123	0.000626	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PDGFA—breast cancer	0.000123	0.000626	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Mitoxantrone—breast cancer	0.000123	0.000219	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Irinotecan—breast cancer	0.000123	0.000219	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Docetaxel—breast cancer	0.000122	0.000218	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000122	0.000623	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000122	0.000622	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Docetaxel—breast cancer	0.000121	0.000217	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Methotrexate—breast cancer	0.000121	0.000216	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Gemcitabine—breast cancer	0.000121	0.000216	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Docetaxel—breast cancer	0.000121	0.000215	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDH7A1—breast cancer	0.00012	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2D6—breast cancer	0.00012	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDH1A1—breast cancer	0.00012	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Somnolence—Docetaxel—breast cancer	0.00012	0.000215	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Methotrexate—breast cancer	0.00012	0.000215	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Gemcitabine—breast cancer	0.00012	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Gemcitabine—breast cancer	0.00012	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—breast cancer	0.00012	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RAF1—breast cancer	0.00012	0.000612	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—breast cancer	0.00012	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Methotrexate—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Gemcitabine—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Fluorouracil—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—breast cancer	0.000119	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Docetaxel—breast cancer	0.000119	0.000212	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITPR1—breast cancer	0.000119	0.000607	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Capecitabine—breast cancer	0.000118	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—breast cancer	0.000118	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Fluorouracil—breast cancer	0.000118	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ABL1—breast cancer	0.000118	0.000603	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA2—breast cancer	0.000118	0.000603	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dermatitis—Fluorouracil—breast cancer	0.000118	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—breast cancer	0.000118	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000118	0.000601	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Capecitabine—breast cancer	0.000118	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Docetaxel—breast cancer	0.000118	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Paclitaxel—breast cancer	0.000118	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000117	0.000599	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Fluorouracil—breast cancer	0.000117	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—RAF1—breast cancer	0.000117	0.000599	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—breast cancer	0.000117	0.000209	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—breast cancer	0.000117	0.000209	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CB—breast cancer	0.000117	0.000597	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—breast cancer	0.000117	0.000209	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Docetaxel—breast cancer	0.000117	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—breast cancer	0.000117	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Capecitabine—breast cancer	0.000117	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Docetaxel—breast cancer	0.000117	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—breast cancer	0.000116	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—breast cancer	0.000116	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Irinotecan—breast cancer	0.000116	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Mitoxantrone—breast cancer	0.000116	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—breast cancer	0.000116	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—breast cancer	0.000116	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Docetaxel—breast cancer	0.000116	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Docetaxel—breast cancer	0.000116	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—breast cancer	0.000115	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ADSL—breast cancer	0.000115	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UMPS—breast cancer	0.000115	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PHGDH—breast cancer	0.000115	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NME1—breast cancer	0.000115	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FHL2—breast cancer	0.000115	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Capecitabine—breast cancer	0.000115	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—breast cancer	0.000115	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000115	0.000585	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ALB—breast cancer	0.000115	0.000585	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—FASN—breast cancer	0.000115	0.000584	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Paclitaxel—breast cancer	0.000114	0.000204	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—BCHE—breast cancer	0.000114	0.000582	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Capecitabine—breast cancer	0.000114	0.000203	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—breast cancer	0.000113	0.000203	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Gemcitabine—breast cancer	0.000113	0.000202	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LDHB—breast cancer	0.000113	0.000577	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPSE—breast cancer	0.000113	0.000577	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—BRIP1—breast cancer	0.000113	0.000577	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Capecitabine—breast cancer	0.000113	0.000202	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Capecitabine—breast cancer	0.000113	0.000201	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A5—breast cancer	0.000113	0.000575	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—breast cancer	0.000113	0.000201	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—breast cancer	0.000112	0.000201	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000112	0.000572	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Constipation—Capecitabine—breast cancer	0.000112	0.0002	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Capecitabine—breast cancer	0.000112	0.0002	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000112	0.00057	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—breast cancer	0.000112	0.000199	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Docetaxel—breast cancer	0.000111	0.000199	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Fluorouracil—breast cancer	0.000111	0.000199	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLA2G4A—breast cancer	0.000111	0.000567	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HGF—breast cancer	0.000111	0.000567	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—breast cancer	0.000111	0.000198	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—breast cancer	0.000111	0.000198	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Docetaxel—breast cancer	0.000111	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—breast cancer	0.00011	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—breast cancer	0.00011	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CSF2—breast cancer	0.00011	0.00056	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—breast cancer	0.00011	0.000196	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—breast cancer	0.000109	0.000195	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Paclitaxel—breast cancer	0.000109	0.000195	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NQO1—breast cancer	0.000109	0.000555	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC2A1—breast cancer	0.000109	0.000555	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—breast cancer	0.000109	0.000194	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000108	0.000552	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—breast cancer	0.000108	0.000193	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Capecitabine—breast cancer	0.000108	0.000193	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—breast cancer	0.000108	0.000192	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—breast cancer	0.000108	0.000549	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—breast cancer	0.000107	0.000548	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—breast cancer	0.000107	0.000192	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—breast cancer	0.000107	0.000192	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—breast cancer	0.000107	0.000192	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HMMR—breast cancer	0.000107	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCC1—breast cancer	0.000107	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA3—breast cancer	0.000107	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Capecitabine—breast cancer	0.000107	0.000191	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—breast cancer	0.000107	0.000191	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Docetaxel—breast cancer	0.000107	0.000191	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—breast cancer	0.000107	0.00019	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP3A4—breast cancer	0.000106	0.000541	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Paclitaxel—breast cancer	0.000105	0.000188	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—breast cancer	0.000105	0.000188	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—breast cancer	0.000105	0.000187	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1B1—breast cancer	0.000104	0.000532	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—breast cancer	0.000104	0.000186	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Capecitabine—breast cancer	0.000104	0.000186	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARGC1B—breast cancer	0.000104	0.00053	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RAF1—breast cancer	0.000104	0.000529	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Capecitabine—breast cancer	0.000103	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—breast cancer	0.000103	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—breast cancer	0.000103	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—breast cancer	0.000103	0.000184	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000103	0.000526	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—breast cancer	0.000103	0.000183	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HSP90AA1—breast cancer	0.000102	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—breast cancer	0.000102	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—breast cancer	0.000102	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—breast cancer	0.000102	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—breast cancer	0.000101	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Paclitaxel—breast cancer	0.000101	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—breast cancer	0.000101	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000101	0.00018	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Paclitaxel—breast cancer	0.000101	0.00018	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Paclitaxel—breast cancer	0.0001	0.000179	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—breast cancer	0.0001	0.000179	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—breast cancer	0.0001	0.000179	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—breast cancer	0.0001	0.000179	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—breast cancer	0.0001	0.000179	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Paclitaxel—breast cancer	9.99e-05	0.000178	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Docetaxel—breast cancer	9.96e-05	0.000178	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA1—breast cancer	9.95e-05	0.000508	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—breast cancer	9.94e-05	0.000177	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—breast cancer	9.9e-05	0.000505	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NCOA1—breast cancer	9.9e-05	0.000505	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—breast cancer	9.87e-05	0.000176	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—breast cancer	9.83e-05	0.000175	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—breast cancer	9.82e-05	0.000175	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA4—breast cancer	9.81e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA9—breast cancer	9.81e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—STK11—breast cancer	9.81e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP19A1—breast cancer	9.81e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—breast cancer	9.74e-05	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Docetaxel—breast cancer	9.7e-05	0.000173	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—breast cancer	9.68e-05	0.000173	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—breast cancer	9.68e-05	0.000173	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—breast cancer	9.65e-05	0.000172	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Capecitabine—breast cancer	9.64e-05	0.000172	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—PLG—breast cancer	9.64e-05	0.000492	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—breast cancer	9.56e-05	0.000171	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—breast cancer	9.56e-05	0.000171	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA2—breast cancer	9.56e-05	0.000488	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPX2—breast cancer	9.56e-05	0.000488	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—breast cancer	9.51e-05	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—breast cancer	9.51e-05	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—breast cancer	9.51e-05	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—breast cancer	9.5e-05	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—breast cancer	9.48e-05	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Paclitaxel—breast cancer	9.48e-05	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—breast cancer	9.47e-05	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.45e-05	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MMP1—breast cancer	9.44e-05	0.000482	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SULT1A1—breast cancer	9.44e-05	0.000482	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPX4—breast cancer	9.44e-05	0.000482	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—breast cancer	9.42e-05	0.000168	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Capecitabine—breast cancer	9.39e-05	0.000168	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SRC—breast cancer	9.38e-05	0.000478	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—breast cancer	9.3e-05	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—breast cancer	9.29e-05	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—breast cancer	9.29e-05	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—breast cancer	9.27e-05	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CDK2—breast cancer	9.27e-05	0.000473	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLAU—breast cancer	9.27e-05	0.000473	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Docetaxel—breast cancer	9.25e-05	0.000165	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—IDH1—breast cancer	9.22e-05	0.00047	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA1—breast cancer	9.22e-05	0.00047	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—breast cancer	9.2e-05	0.000164	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—breast cancer	9.14e-05	0.000163	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—breast cancer	9.13e-05	0.000466	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—breast cancer	9.12e-05	0.000163	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NAT2—breast cancer	9.12e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—COMT—breast cancer	9.12e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—breast cancer	9.09e-05	0.000162	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTP1—breast cancer	9.07e-05	0.000463	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—breast cancer	9.06e-05	0.000162	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CAV1—breast cancer	9.05e-05	0.000462	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MDM2—breast cancer	9.02e-05	0.00046	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—RAF1—breast cancer	8.99e-05	0.000459	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—breast cancer	8.97e-05	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—breast cancer	8.96e-05	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Capecitabine—breast cancer	8.96e-05	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HMOX1—breast cancer	8.95e-05	0.000457	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—breast cancer	8.94e-05	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Docetaxel—breast cancer	8.94e-05	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ITPR1—breast cancer	8.93e-05	0.000456	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—breast cancer	8.93e-05	0.000159	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—HMOX1—breast cancer	8.9e-05	0.000454	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—breast cancer	8.88e-05	0.000159	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—breast cancer	8.86e-05	0.000158	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—breast cancer	8.82e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—breast cancer	8.81e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—breast cancer	8.8e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—breast cancer	8.8e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—breast cancer	8.8e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—breast cancer	8.77e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—breast cancer	8.75e-05	0.000156	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.74e-05	0.000156	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—breast cancer	8.69e-05	0.000155	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—breast cancer	8.69e-05	0.000155	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—breast cancer	8.66e-05	0.000155	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Capecitabine—breast cancer	8.66e-05	0.000155	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK3—breast cancer	8.64e-05	0.000441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—FN1—breast cancer	8.62e-05	0.00044	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—breast cancer	8.61e-05	0.000154	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Docetaxel—breast cancer	8.6e-05	0.000153	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.59e-05	0.000439	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCB1—breast cancer	8.59e-05	0.000438	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—breast cancer	8.58e-05	0.000153	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB1—breast cancer	8.54e-05	0.000436	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Docetaxel—breast cancer	8.53e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Docetaxel—breast cancer	8.52e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS2—breast cancer	8.51e-05	0.000434	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—breast cancer	8.51e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—breast cancer	8.47e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Docetaxel—breast cancer	8.47e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—breast cancer	8.44e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TYMS—breast cancer	8.43e-05	0.00043	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—breast cancer	8.41e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—breast cancer	8.4e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—breast cancer	8.38e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TGFB1—breast cancer	8.38e-05	0.000428	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PLA2G4A—breast cancer	8.34e-05	0.000425	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTM1—breast cancer	8.34e-05	0.000425	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOR1—breast cancer	8.34e-05	0.000425	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—breast cancer	8.33e-05	0.000149	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Capecitabine—breast cancer	8.32e-05	0.000149	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—breast cancer	8.31e-05	0.000148	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—breast cancer	8.3e-05	0.000148	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—breast cancer	8.28e-05	0.000148	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Capecitabine—breast cancer	8.25e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—breast cancer	8.25e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Capecitabine—breast cancer	8.25e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CG—breast cancer	8.25e-05	0.000421	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Capecitabine—breast cancer	8.2e-05	0.000146	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—breast cancer	8.2e-05	0.000146	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—breast cancer	8.19e-05	0.000146	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—breast cancer	8.16e-05	0.000146	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EGF—breast cancer	8.15e-05	0.000416	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—breast cancer	8.13e-05	0.000145	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—breast cancer	8.11e-05	0.000145	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—breast cancer	8.04e-05	0.000144	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Docetaxel—breast cancer	8.03e-05	0.000143	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—breast cancer	8.03e-05	0.000143	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—breast cancer	8.03e-05	0.000143	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MED12—breast cancer	7.99e-05	0.000408	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—DPYD—breast cancer	7.99e-05	0.000408	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GPX1—breast cancer	7.98e-05	0.000407	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—breast cancer	7.97e-05	0.000142	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—breast cancer	7.93e-05	0.000142	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1A1—breast cancer	7.9e-05	0.000403	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—breast cancer	7.87e-05	0.000141	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDOA—breast cancer	7.87e-05	0.000402	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—breast cancer	7.86e-05	0.00014	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ERCC2—breast cancer	7.84e-05	0.0004	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—breast cancer	7.8e-05	0.000139	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—breast cancer	7.8e-05	0.000139	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Capecitabine—breast cancer	7.78e-05	0.000139	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—breast cancer	7.76e-05	0.000396	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—breast cancer	7.74e-05	0.000138	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—breast cancer	7.7e-05	0.000138	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.69e-05	0.000137	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA3—breast cancer	7.64e-05	0.00039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—breast cancer	7.63e-05	0.000136	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC2A2—breast cancer	7.59e-05	0.000387	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—breast cancer	7.58e-05	0.000135	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IGF1—breast cancer	7.55e-05	0.000385	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT2—breast cancer	7.54e-05	0.000385	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—breast cancer	7.52e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—breast cancer	7.52e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—breast cancer	7.5e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—breast cancer	7.46e-05	0.000133	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCG2—breast cancer	7.43e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CPT1A—breast cancer	7.43e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTR—breast cancer	7.43e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—breast cancer	7.43e-05	0.000133	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTHFR—breast cancer	7.37e-05	0.000376	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—breast cancer	7.34e-05	0.000131	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGDS—breast cancer	7.29e-05	0.000372	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—breast cancer	7.29e-05	0.00013	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—breast cancer	7.28e-05	0.00013	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CD—breast cancer	7.25e-05	0.00037	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—breast cancer	7.24e-05	0.000129	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HBA1—breast cancer	7.24e-05	0.00037	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—breast cancer	7.22e-05	0.000129	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—breast cancer	7.22e-05	0.000129	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—breast cancer	7.21e-05	0.000129	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—breast cancer	7.18e-05	0.000128	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SERPINE1—breast cancer	7.17e-05	0.000366	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ALB—breast cancer	7.16e-05	0.000365	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—breast cancer	7.13e-05	0.000364	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACHE—breast cancer	7.07e-05	0.000361	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTT1—breast cancer	7.07e-05	0.000361	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—breast cancer	6.99e-05	0.000125	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—breast cancer	6.95e-05	0.000124	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—breast cancer	6.9e-05	0.000123	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—breast cancer	6.9e-05	0.000352	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS3—breast cancer	6.84e-05	0.000349	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CAV1—breast cancer	6.8e-05	0.000347	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—breast cancer	6.72e-05	0.00012	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—breast cancer	6.7e-05	0.00012	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP17A1—breast cancer	6.69e-05	0.000341	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—breast cancer	6.67e-05	0.000119	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—breast cancer	6.67e-05	0.000119	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS1—breast cancer	6.62e-05	0.000338	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ENO1—breast cancer	6.62e-05	0.000338	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HRAS—breast cancer	6.6e-05	0.000337	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—breast cancer	6.54e-05	0.000117	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2D6—breast cancer	6.5e-05	0.000331	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAF1—breast cancer	6.47e-05	0.00033	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—HRAS—breast cancer	6.46e-05	0.00033	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—breast cancer	6.44e-05	0.000115	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA2—breast cancer	6.38e-05	0.000325	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CB—breast cancer	6.32e-05	0.000322	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—breast cancer	6.24e-05	0.000111	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—breast cancer	6.22e-05	0.000111	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—breast cancer	6.2e-05	0.000111	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ALB—breast cancer	6.19e-05	0.000316	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CG—breast cancer	6.19e-05	0.000316	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FASN—breast cancer	6.18e-05	0.000316	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—BCHE—breast cancer	6.16e-05	0.000314	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—breast cancer	6.14e-05	0.00011	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—breast cancer	6.14e-05	0.00011	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—breast cancer	6.1e-05	0.000109	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A5—breast cancer	6.08e-05	0.00031	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—breast cancer	6.05e-05	0.000108	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—breast cancer	6.03e-05	0.000108	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NQO1—breast cancer	5.87e-05	0.0003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC2A1—breast cancer	5.87e-05	0.0003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—breast cancer	5.83e-05	0.000297	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—breast cancer	5.8e-05	0.000296	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—breast cancer	5.8e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—breast cancer	5.79e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—breast cancer	5.77e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—breast cancer	5.75e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—breast cancer	5.74e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP3A4—breast cancer	5.73e-05	0.000292	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—breast cancer	5.71e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1B1—breast cancer	5.63e-05	0.000287	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RAF1—breast cancer	5.6e-05	0.000286	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—breast cancer	5.58e-05	9.96e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSP90AA1—breast cancer	5.52e-05	0.000282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CD—breast cancer	5.44e-05	0.000278	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—breast cancer	5.42e-05	9.67e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA1—breast cancer	5.37e-05	0.000274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALB—breast cancer	5.37e-05	0.000274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—breast cancer	5.37e-05	9.58e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ALB—breast cancer	5.34e-05	0.000273	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—breast cancer	5.32e-05	9.5e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—breast cancer	5.32e-05	9.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—STK11—breast cancer	5.3e-05	0.00027	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP19A1—breast cancer	5.3e-05	0.00027	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—breast cancer	5.29e-05	9.44e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NOS3—breast cancer	5.14e-05	0.000262	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SRC—breast cancer	5.06e-05	0.000258	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—breast cancer	5.01e-05	8.95e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—HRAS—breast cancer	4.95e-05	0.000253	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—breast cancer	4.93e-05	0.000252	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—COMT—breast cancer	4.92e-05	0.000251	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTP1—breast cancer	4.9e-05	0.00025	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RAF1—breast cancer	4.83e-05	0.000247	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HMOX1—breast cancer	4.83e-05	0.000247	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ITPR1—breast cancer	4.82e-05	0.000246	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CB—breast cancer	4.74e-05	0.000242	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—breast cancer	4.7e-05	0.00024	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK3—breast cancer	4.66e-05	0.000238	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCB1—breast cancer	4.64e-05	0.000237	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TYMS—breast cancer	4.55e-05	0.000232	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TGFB1—breast cancer	4.53e-05	0.000231	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PLA2G4A—breast cancer	4.5e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM1—breast cancer	4.5e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOR1—breast cancer	4.5e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPX1—breast cancer	4.31e-05	0.00022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1A1—breast cancer	4.27e-05	0.000218	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ERCC2—breast cancer	4.23e-05	0.000216	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—breast cancer	4.19e-05	0.000214	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—breast cancer	4.1e-05	0.000209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTHFR—breast cancer	3.98e-05	0.000203	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—breast cancer	3.85e-05	0.000197	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—breast cancer	3.73e-05	0.00019	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CAV1—breast cancer	3.67e-05	0.000187	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HRAS—breast cancer	3.56e-05	0.000182	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CG—breast cancer	3.34e-05	0.000171	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—breast cancer	3.15e-05	0.000161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CD—breast cancer	2.94e-05	0.00015	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALB—breast cancer	2.9e-05	0.000148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—breast cancer	2.89e-05	0.000148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NOS3—breast cancer	2.78e-05	0.000142	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CB—breast cancer	2.56e-05	0.000131	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—breast cancer	2.54e-05	0.00013	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—breast cancer	2.36e-05	0.000121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—breast cancer	2.21e-05	0.000113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—breast cancer	1.56e-05	7.97e-05	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—breast cancer	1.28e-05	6.51e-05	CbGpPWpGaD
